Literature DB >> 8396414

Unexpected patterns of Epstein-Barr virus gene expression during early stages of B cell transformation.

R K Cheung1, I Miyazaki, H M Dosch.   

Abstract

Following Epstein-Barr virus (EBV) binding to its CD21 cell surface receptor, virus internalization, nuclear translocation, and circularization of the viral episome were found to occur within 30 min, immediately preceding the expression of EB nuclear antigen (EBNA)-1 and -2 and latent membrane protein (LMP)-1 and -2 genes. Early viral gene expression was unaffected by blockade of the virus induced, transformation-prerequisite cellular activation pathway (Ca2+ currents, tyrosine phosphorylation, induction of p56lck, hsp70, and hsp90). Despite life times of only 3 h, antisense (but not sense) oligonucleotides for the above latency genes prevented subsequent transformation. Any one antisense oligonucleotide dramatically depleted transcripts not only of the target gene, but of all other latency genes. The blocking effect of antisense oligonucleotides allowed us to identify a new transformation-prerequisite latency gene near the fused termini. The concerted regulation of EBV gene expression is highly unusual and unexplained but our results imply critical, perhaps regulatory roles for initial latency gene transcripts themselves.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396414     DOI: 10.1093/intimm/5.7.707

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  2 in total

1.  RNAs in Epstein-Barr virions control early steps of infection.

Authors:  Simon Jochum; Romana Ruiss; Andreas Moosmann; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-27       Impact factor: 11.205

2.  Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma: possible role in the development of overt lymphoma in immunocompetent hosts.

Authors:  H Kanno; N Naka; Y Yasunaga; K Iuchi; S Yamauchi; M Hashimoto; K Aozasa
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.